Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1038/sj.onc.1210266
Read article for free, from open access legal sources, via Unpaywall: https://www.nature.com/articles/1210266.pdf
References
Articles referenced by this article (14)
Alterations in DNA methylation: a fundamental aspect of neoplasia.
Adv Cancer Res, 141-196 1998
MED: 9338076
H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein.
Cancer Res, (13):2904-2907 1996
MED: 8674037
Title not supplied
Nat Rev Genet 2001
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Cancer Res, (17):5956-5962 2004
MED: 15342374
A fine-structure deletion map of human chromosome 11p: analysis of J1 series hybrids.
Somat Cell Mol Genet, (6):477-501 1989
MED: 2595451
Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
Eur J Biochem, (3):924-932 1999
MED: 10411657
Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells.
J Clin Endocrinol Metab, (6):1766-1771 1997
MED: 9177379
Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells.
Carcinogenesis, (11):1885-1895 2002
MED: 12419837
Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA.
Oncogene, (10):1625-1631 2002
MED: 11896592
Show 4 more references (10 of 14)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Novel insights on oral squamous cell carcinoma management using long non-coding RNAs.
Oncol Res, 32(10):1589-1612, 18 Sep 2024
Cited by: 0 articles | PMID: 39308526 | PMCID: PMC11413828
Review Free full text in Europe PMC
The expression and function of long noncoding RNAs in hepatocellular carcinoma.
Cancer Innov, 2(6):488-499, 15 Aug 2023
Cited by: 2 articles | PMID: 38125766 | PMCID: PMC10730004
Review Free full text in Europe PMC
Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.
Front Pharmacol, 14:1243934, 15 Sep 2023
Cited by: 1 article | PMID: 37781691 | PMCID: PMC10540237
Review Free full text in Europe PMC
Associations between non-coding RNAs genetic polymorphisms with ovarian cancer risk: A systematic review and meta-analysis update with trial sequential analysis.
Medicine (Baltimore), 102(39):e35257, 01 Sep 2023
Cited by: 1 article | PMID: 37773807 | PMCID: PMC10545158
Review Free full text in Europe PMC
TLSEA: a tool for lncRNA set enrichment analysis based on multi-source heterogeneous information fusion.
Front Genet, 14:1181391, 02 May 2023
Cited by: 1 article | PMID: 37205123 | PMCID: PMC10185877
Go to all (125) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Chin Med J (Engl), 114(9):929-932, 01 Sep 2001
Cited by: 2 articles | PMID: 11780384
Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chin Med J (Engl), 120(8):703-707, 01 Apr 2007
Cited by: 8 articles | PMID: 17517188
Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
Eur J Pharmacol, 654(2):129-134, 31 Dec 2010
Cited by: 29 articles | PMID: 21195709
Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Hepatobiliary Pancreat Dis Int, 5(4):552-559, 01 Nov 2006
Cited by: 8 articles | PMID: 17085341